ResearchHSR26-207: Real-World Survival and Toxicity Outcomes of Tarlatamab in Relapsed or Refractory Small-Cell Lung Cancer: A Multicenter TriNetX Analysis Across Academic and Non-Academic Centers
ResearchPOSTER: MM-1482: Acute Kidney Injury as a Risk Stratification Tool in Multiple Myeloma: Insights From a Nationwide Analysis of Mortality and 30-Day Readmission
ResearchDrivers of early readmission and mortality after metastatic spinal cord compression in cervical cancer: Real-world evidence on disease progression, infection, and palliative gaps
ResearchDifferential impact of venous thromboembolism and metastatic disease on in-hospital mortality and 30-day readmission in pancreatic cancer: A Nationwide Readmissions Database analysis
ResearchInpatient outcomes of diabetic ketoacidosis complicating pancreatic cancer: a national inpatient sample analysis
ResearchLuspatercept and thrombotic events in patients with myelodysplastic syndrome: a target trial emulation framework using TriNetX database
ResearchInsulin pump use and hospital outcomes in adults with type 1 diabetes: a 2022 Nationwide Readmissions Database analysis
ResearchOutcomes of Cerebral Venous Thrombosis in Patients With Myeloproliferative Neoplasms from a U.S. Nationwide Hospitalization Study
ResearchPredictors of 30-day readmissions post-CAR-T in patients with relapsed/refractory multiple myeloma using the United States nationwide readmission database
ResearchRisk of second primary hematological malignancy post CAR-T cell therapy in relapsed/refractory multiple myeloma: Propensity-matched analysis using TriNetX database
ResearchIntegrating Circulating Tumor DNA into Clinical Management of Colorectal Cancer: Practical Implications and Therapeutic Challenges